From: The impact of low-frequency, low-force cyclic stretching of human bronchi on airway responsiveness
 |  | Cyclic stretch effect on post-stretch response, difference between control and stretch group | Effect of pretreatment | Effect size pretreatment | |
---|---|---|---|---|---|
n | in absence of pretreatment (g) | in presence of pretreatment (g) | (g) | |d| [95% CI] | |
Epithelium removal | 13 | 0.24 ± 0.03a | 0.15 ± 0.03a | −0.09 ± 0.03d | −3.00 [−4.01– − 1.80] |
Indomethacin (1 μ M) | 8 | 0.36 ± 0.07b | 0.29 ± 0.07b | −0.07 ± 0.11 | −0.37 [−1.34–0.64] |
MK476 (1 μM) | 7 | 0.35 ± 0.08b | 0.23 ± 0.06c | −0.12 ± 0.10 | −0.64 [−1.67–0.47] |
L-NAME (1 mM) | 14 | 0.29 ± 0.03a | 0.21 ± 0.03a | −0.08 ± 0.02d | −0.73 [−1.47–0.06] |
Nicardipine (10 μM) | 10 | 0.17 ± 0.03a | 0.12 ± 0.08a | −0.05 ± 0.07 | −0.27 [−1.13–0.63] |
Tetrodotoxin (1 μM) | 7 | 0.37 ± 0.08b | 0.29 ± 0.06b | −0.07 ± 0.10 | −0.43 [−1.46–0.66] |
Gadolinium (0.1 mM) | 8 | 0.36 ± 0.07b | 0.26 ± 0.03a | −0.10 ± 0.08 | −0.69 [−1.65 − 0.36] |
Tertiapine (10 μM) | 9 | 0.23 ± 0.06b | 0.27 ± 0.04a | 0.04 ± 0.08 | 0.26 [−0.68–1.18] |
Capsazepine (1 μM) | 8 | 0.29 ± 0.06b | 0.37 ± 0.05a | 0.08 ± 0.06 | 0.74 [−0.31–1.71] |
Calphostine C (0.1 μM) | 9 | 0.21 ± 0.03a | 0.26 ± 0.02a | 0.05 ± 0.05 | 0.65 [−0.32–1.57] |
SB203580 (0.1 μM) | 10 | 0.29 ± 0.05a | 0.15 ± 0.19 | −0.14 ± 0.22 | −0.32 [−1.19–0.58] |
Y27632 (1 μM) | 11 | 0.28 ± 0.05a | 0.33 ± 0.07b | 0.05 ± 0.08 | 0.25 [−0.60–1.08] |